FundingWatcher
Home / Startups / Top health care startups / Health care startups that raised Series B / Health care startups that raised Series B in Jiangsu, China

Health care startups that raised Series B in Jiangsu, China

Updated 16 Nov 2026

Reset
Health care startups that raised Series B in Jiangsu, China
One-time CSV
  • 85 funded companies, 68 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-health-care--series-b~jiangsu-china.csv85 rows × 18 columns
CompanyCityLast roundAmountDate
Yuce BiotechnologySuzhouSeries B$7.4M2026-08-31
HemaCellSuzhouSeries B$14.8M2026-06-02
AccuPulseSuzhouSeries B$14.5M2026-03-13
Tingsheng TechnologyNanjingSeries B$13.9M2026-03-05
D3 BioWuxi ShiSeries B$108.0M2025-12-09
Hope MedicineNanjingSeries B$18.5M2024-09-27
Tuge Medical TechnologyNanjingSeries B$27.7M2024-04-10
CureGeneticsSuzhouSeries B$9.0M2024-03-28

8 rows of the CSV in 5 of its 18 columns.

85
Startups
$2.3B
Total raised
14
Funded in the last 12 months
$256.8M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

11 of 85
11 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Yuce Biotechnology Yuce Biotechnology focuses on the industrialization of single-molecule immunodiagnostic technologies. Biotech Suzhou Series B $7.4M 2026-08-31 $22.4M Puhua Capital, Zhengxuan Investment, BioTrack Capital +2 101 to 250 2019
HemaCell HemaCell develops cell therapies that regenerate hematopoietic lineages in vitro through stem cell reprogramming. Biotech Suzhou Series B $14.8M 2026-06-02 $62.0M Northern Light Venture Capital, CDH Investments, CMB International Capital Corporation 1 to 10 2021
AccuPulse AccuPulse develops pulsed electric field ablation generators and catheters. Health care Suzhou Series B $14.5M 2026-03-13 $72.5M BioVenture, Shanghai Biomedical Industrial Equity Investment Fund, Med-Fine Capital +1 11 to 50 2020
Tingsheng Technology Tingsheng Technology develops intracardiac ultrasound (ICE) products. Health care Nanjing Series B $13.9M 2026-03-05 $52.8M Qiming Venture Partners, Taiyu Investment, Tao Capital +2 2017
D3 Bio D3 Bio develops and registers medicines as a biotechnology company. Biotech Wuxi Shi Series B $108.0M 2025-12-09 $370.0M Matrix Partners China, Boyu Capital, Medicxi 1 to 10 2020
Hope Medicine Hope Medicine develops science-driven biopharmaceutical treatments in clinical development. Health care Nanjing Series B $18.5M 2024-09-27 $102.6M Qiming Venture Partners, Sinovation Ventures, Trustbridge Partners +2 1 to 10 2018
Tuge Medical Technology Tuge Medical Technology develops and industrializes 4K endoscopic imaging equipment and digital operating rooms. Health care Nanjing Series B $27.7M 2024-04-10 $27.7M LongRiver Investments 101 to 250 2018
CureGenetics CureGenetics develops medicines and molecular diagnostics for cancers and genetic diseases. Biotech Suzhou Series B $9.0M 2024-03-28 Qiming Venture Partners, Oriza Holdings, Qingsong Fund +1 51 to 100 2016
Onechip Bioelectronics Onechip Bioelectronics develops biosensor chips and nanomaterials. Biotech Zhangjiagang Series B $13.7M 2023-09-28 Matrix Partners China, Qiming Venture Partners, Xiamen C&D Emerging Industry Equity Investment +1 11 to 50 2014
Chamlion Chamlion provides end-to-end digital dentistry solutions based on 3D printing. Hardware Nanjing Series B $34.3M 2023-04-19 Vertex Ventures China, Zhencheng Capital, 3H Health Investment +1 501 to 1,000 2017
Weiyun AI Weiyun AI combines medical health and artificial intelligence to manufacture clinical dental products. Artificial intelligence Nanjing Series B $15.2M 2021-03-30 AlphaX Partners 1 to 10 2018

Table 1. Health care startups that raised Series B in Jiangsu, China: the 11 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 85.

Largest rounds

Last 12 months
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 D3 Bio D3 Bio develops and registers medicines as a biotechnology company. Biotech Wuxi Shi Series B $108.0M 2025-12-09 $370.0M Matrix Partners China, Boyu Capital, Medicxi 1 to 10 2020
2 HemaCell HemaCell develops cell therapies that regenerate hematopoietic lineages in vitro through stem cell reprogramming. Biotech Suzhou Series B $14.8M 2026-06-02 $62.0M Northern Light Venture Capital, CDH Investments, CMB International Capital Corporation 1 to 10 2021
3 AccuPulse AccuPulse develops pulsed electric field ablation generators and catheters. Health care Suzhou Series B $14.5M 2026-03-13 $72.5M BioVenture, Shanghai Biomedical Industrial Equity Investment Fund, Med-Fine Capital +1 11 to 50 2020
4 Tingsheng Technology Tingsheng Technology develops intracardiac ultrasound (ICE) products. Health care Nanjing Series B $13.9M 2026-03-05 $52.8M Qiming Venture Partners, Taiyu Investment, Tao Capital +2 2017
5 Yuce Biotechnology Yuce Biotechnology focuses on the industrialization of single-molecule immunodiagnostic technologies. Biotech Suzhou Series B $7.4M 2026-08-31 $22.4M Puhua Capital, Zhengxuan Investment, BioTrack Capital +2 101 to 250 2019

Table 2. Health care startups that raised Series B in Jiangsu, China: the 5 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Qiming Venture Partners Venture capital firm Shanghai, China 4 5% 1 Tingsheng Technology
2 Puhua Capital Venture capital firm Hangzhou, China 2 2% 1 Yuce Biotechnology
3 Matrix Partners China Venture capital firm Beijing, China 2 2% 1 D3 Bio
4 Vertex Ventures China Venture capital firm Beijing, China 2 2%
5 LH Ventures Private equity firm Shanghai, China 1 1% 1 Yuce Biotechnology
6 BioTrack Capital Venture capital firm Shanghai, China 1 1% 1 Yuce Biotechnology
7 Boyuan Capital Venture capital firm Shanghai, China 1 1% 1 Yuce Biotechnology
8 Zhengxuan Investment Venture capital firm Shenzhen, China 1 1% 1 Yuce Biotechnology
9 CDH Investments Private equity firm Kowloon City, Hong Kong 1 1% 1 HemaCell
10 Northern Light Venture Capital Venture capital firm Beijing, China 1 1% 1 HemaCell
11 CMB International Capital Corporation Investment bank Central, Hong Kong 1 1% 1 HemaCell
12 Med-Fine Capital Venture capital firm Shanghai, China 1 1% 1 AccuPulse
13 BioVenture Venture capital firm Suzhou, China 1 1% 1 AccuPulse
14 Shanghai Biomedical Industrial Equity Investment Fund Venture capital firm Huangpu, China 1 1% 1 AccuPulse
15 Blue Bay Ventures Venture capital firm California City, United States 1 1% 1 AccuPulse

Table 3. Health care startups that raised Series B in Jiangsu, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 43 51% $1.5B
Hardware 8 9% $14.0M
Software 7 8% $14.0M
Commerce 3 4% $88.7M
Artificial intelligence 2 2% $14.0M

Table 4. Health care startups that raised Series B in Jiangsu, China by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series B 85 100% $18.0M

Table 5. Health care startups that raised Series B in Jiangsu, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Suzhou 45 53%
Nanjing 26 31%
Taizhou 3 4%
Nantong 2 2%
Wuxi Shi 2 2%
Suzhou Shi 1 1%
Lianyungang 1 1%
Zhangjiagang 1 1%
Yangzhou 1 1%
Changsha 1 1%
Jiangyin 1 1%
Pizhou 1 1%

Table 6. Health care startups that raised Series B in Jiangsu, China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
August 2026 1 7% $7.4M
June 2026 1 7% $14.8M
May 2026 2 14% $54.7M
March 2026 2 14% $28.5M
January 2026 3 21% $29.2M
December 2025 4 29% $122.3M
November 2025 1 7%

Table 7. Health care startups that raised Series B in Jiangsu, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 9 11% $134.6M
2025 16 19% $177.9M
2024 7 8% $73.1M
2023 13 15% $297.6M
2022 13 15% $316.5M
2021 6 7% $171.9M

Table 8. Health care startups that raised Series B in Jiangsu, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2020 to 2022 16 19%
2015 to 2019 40 48%
2010 to 2014 15 18%
Before 2010 13 15%

Table 9. Health care startups that raised Series B in Jiangsu, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 11 15%
11 to 50 18 25%
51 to 100 16 22%
101 to 250 17 24%
251 to 500 5 7%
501 to 1,000 5 7%

Table 10. Health care startups that raised Series B in Jiangsu, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many health care startups in Jiangsu, China whose last round is Series B are on the list?
85, in the file dated 16 November 2026. 14 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 85 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Health care startups that raised Series B in Jiangsu, China: 85 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Health care at other stages in Jiangsu

Other sectors that raised Series B in Jiangsu

Cite: FundingWatcher, 85 health care companies in Jiangsu, China whose most recent round is Series B, 16 November 2026. https://fundingwatcher.com/startups/health-care/series-b/jiangsu-china/